Curis | CRIS - Текущие активы





Текущие активы Изменить Дата
Alaunos Therapeutics USD 970K 1.02M 2026-03
Amgen USD 34.96B 3.49B 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
Bayer EUR 33.64B 1.66B 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
CSL USD 11.85B 1000K 2025-12
Curis USD 16.61M 9.7M 2026-03
Eli Lilly USD 64.67B 9.84B 2026-06
Exelixis USD 1.25B 42.18M 2026-06
Gilead Sciences USD 12.53B 6.11B 2026-06
GlaxoSmithKline GBP 17.56B 202M 2026-06
Incyte USD 6.03B 542.31M 2026-06
Merck USD 36.68B 1.66B 2026-06
Novartis USD 27.35B 744M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
Takeda JPY 3.15T 59.77B 2026-06
TG Therapeutics USD 1.15B 58.72M 2026-06
Verastem USD 202.9M 20.51M 2026-03